1 – 50 of 247
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis : 2023 update
2024) In Annals of the Rheumatic Diseases(
- Contribution to journal › Article
- 2023
-
Mark
DIGITAL SELF-MANAGEMENT, ANALGESIC USE AND PATIENT-REPORTED OUTCOMES IN KNEE OR HIP OSTEOARTHRITIS
(
- Contribution to journal › Published meeting abstract
- 2022
-
Mark
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus : data from the COVID-19 Global Rheumatology Alliance
(
- Contribution to journal › Article
-
Mark
LEVELS OF IL-6 AND OTHER INFLAMMATORY PROTEINS IN EARLY RA PREDICT JOINT DAMAGE PROGRESSION OVER 5 YEARS
(
- Contribution to journal › Published meeting abstract
-
Mark
Development and validation of a patient-reported outcome measure for systemic sclerosis : the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire
(
- Contribution to journal › Article
-
Mark
Flares after hydroxychloroquine reduction or discontinuation : results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort
(
- Contribution to journal › Article
- 2020
-
Mark
Increased risk of multiple myeloma in primary Sjögren's syndrome is limited to individuals with Ro/SSA and La/SSB autoantibodies
(
- Contribution to journal › Letter
-
Mark
High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies
(
- Contribution to journal › Article
- 2019
-
Mark
“TO REGAIN ONE’S HEALTH” – PATIENTS’ PREFERENCES OF TREATMENT OUTCOMES IN EARLY RHEUMATOID ARTHRITIS – A QUALITATIVE STUDY
(
- Contribution to journal › Published meeting abstract
-
Mark
Tight control management of early RA achieves more patients in remission at 6 months and improves pain, function and Fatigue at 24 months compared to a control group
(
- Contribution to journal › Published meeting abstract
-
Mark
PREDICTORS OF EROSION AND JOINT SPACE NARROWING PROGRESSION IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS
(
- Contribution to journal › Published meeting abstract
- 2018
-
Mark
Ultrasonography in psoriatic arthritis: Which sites should we scan?
(
- Contribution to journal › Letter
- 2017
-
Mark
Knee extensor strength and body weight in adolescent men and the risk of knee osteoarthritis by middle age
(
- Contribution to journal › Article
-
Mark
Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register.
(
- Contribution to journal › Article
-
Mark
Burden of musculoskeletal disorders in the Eastern Mediterranean Region, 1990-2013 : findings from the Global Burden of Disease Study 2013
(
- Contribution to journal › Article
- 2016
-
Mark
Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.
(
- Contribution to journal › Article
-
Mark
Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).
(
- Contribution to journal › Article
-
Mark
Mortality in ankylosing spondylitis: results from a nationwide population-based study.
(
- Contribution to journal › Article
-
Mark
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update.
(
- Contribution to journal › Article
-
Mark
Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts.
2016) In Annals of the Rheumatic Diseases(
- Contribution to journal › Article
-
Mark
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis
(
- Contribution to journal › Article
-
Mark
Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
(
- Contribution to journal › Article
- 2015
-
Mark
Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial
(
- Contribution to journal › Article
-
Mark
Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab
(
- Contribution to journal › Article
-
Mark
Nitrosative modifications of the Ca2+ release complex and actin underlie arthritis-induced muscle weakness.
(
- Contribution to journal › Article
-
Mark
Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial.
(
- Contribution to journal › Article
-
Mark
Incidence and mortality rates of biopsy-proven giant cell arteritis in southern Sweden.
(
- Contribution to journal › Article
-
Mark
Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial.
(
- Contribution to journal › Article
-
Mark
The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study.
(
- Contribution to journal › Article
-
Mark
Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.
(
- Contribution to journal › Article
-
Mark
The effects of rheumatoid factor and anticitrullinated peptide antibodies on bone erosions in rheumatoid arthritis.
(
- Contribution to journal › Letter
-
Mark
Development of patient-centred standards of care for osteoarthritis in Europe: the eumusc.net-project.
(
- Contribution to journal › Article
-
Mark
Autoimmune diseases in Adult Life after Childhood Cancer in Scandinavia (ALiCCS).
2015) In Annals of the Rheumatic Diseases(
- Contribution to journal › Article
-
Mark
Evaluation of the association between anticarbamylated protein antibodies and the longitudinal course of functional ability in rheumatoid arthritis.
2015) In Annals of the Rheumatic Diseases(
- Contribution to journal › Letter
-
Mark
Validation of the Swedish Version of Start Back Too Against the Short Version of The Örebro Musculoskeletal Pain Screening Questionnaire in Patients with Back and/or Neck Pain in Primary Health Care
(
- Contribution to journal › Published meeting abstract
-
Mark
Clinician Reported Outcomes Measures, CROMs, in RMDS.
(
- Contribution to journal › Published meeting abstract
-
Mark
PXK locus in systemic lupus erythematosus: fine mapping and functional analysis reveals novel susceptibility gene ABHD6
(
- Contribution to journal › Article
-
Mark
Damage in the anca-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trials
(
- Contribution to journal › Article
-
Mark
Impact of early disease factors on metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort
(
- Contribution to journal › Article
-
Mark
Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial.
(
- Contribution to journal › Article
-
Mark
Prophylactic treatment with S100A9 inhibitor paquinimod reduces pathology in experimental collagenase-induced osteoarthritis.
(
- Contribution to journal › Article
- 2014
-
Mark
A meta-analysis of genome-wide association studies identifies novel variants associated with osteoarthritis of the hip
(
- Contribution to journal › Article
-
Mark
International comparisons of the consultation prevalence of musculoskeletal conditions using population-based healthcare data from England and Sweden
(
- Contribution to journal › Article
-
Mark
Lymphoma risk in systemic lupus: effects of disease activity versus treatment
(
- Contribution to journal › Article
-
Mark
Smoking as a risk factor for the radiological severity of rheumatoid arthritis: a study on six cohorts
(
- Contribution to journal › Article
-
Mark
Validation of EULAR primary Sjogren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)
(
- Contribution to journal › Article
-
Mark
Development of patient-centred standards of care for rheumatoid arthritis in Europe: the eumusc.net project
(
- Contribution to journal › Article
-
Mark
Development of healthcare quality indicators for rheumatoid arthritis in Europe: the eumusc.net project.
(
- Contribution to journal › Article
-
Mark
Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort.
(
- Contribution to journal › Article